ImmunoGen Inc
IMGN·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$31.27
Today
+0.0%
YTD
+0.2%
About
Operating internationally, ImmunoGen is a clinical-stage biotechnology company. The company develops cancer treatments using antibody-based therapies. With headquarters based in Waltham, Massachusetts, the company was founded in 1980. ImmunoGen stock is available on the NASDAQ GS stock market under the IMGN ticker. Make IMGN stock an entry on your eToro watchlist to keep up with its price movements.
Price chart
Closing price history for IMGN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-104.24
P/S (TTM)31.23
P/B (TTM)14.78
Market cap$8.72B
Cap tierMid-cap
Industry avg P/E-2.16
Profitability
Gross margin98.51%
EBIT margin-27.88%
Net margin27.11%
ROE-19.88%
ROA-12.45%
Earnings & Revenue
Revenue (TTM)$287.61M
Revenue growth (1Y)+200.8%
EPS (TTM)-$0.30
Free cash flow$-199.78M
Total debt$110.22M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.30
Employees277
Next earnings29 Feb '24
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.